semaglutide 2025 Novo Nordisk H1 2025: Unseats Keytruda from Top with USD 16.7b in Sales Semaglutide / Cyanocobalamin Injection |

That changed at the end of 2025, when the FDA approved the Wegovy pill (oral semaglutide 25 mg), making it the first and only oral GLP-1 medication approved for chronic weight management in adults

Its a medication used for weight loss, working by stimulating the bodys insulin response and reducing hunger

Tip: Even a quick stroll for 5-10 minutes after a meal can help reduce blood sugar levels

The focus is often on managing obesity as a medical condition, rather than purely cosmetic weight loss

We delve into the fascinating world of GLP-1 treatments, providing honest, tried-and-true insights to help you reap the maximum metabolic health and weight control benefits from your medication

Long-term obesity management points toward semaglutide